Enhancer ID: | E_01_0801 |
Species: | human |
Position : | chr21:34784861-34786861 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Prostatic cancer |
Pubmed ID: | 30016502 |
Enhancer experiment: | Reverse transcription quantitative PCR, RNA SEQ, chip SEQ, chip qPCR, statistical analysis |
Enhancer experiment description: | The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. ;The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. |
TF name : | RUNX1(AML1,AML1-EVI-1,AMLCR1,CBF2alpha,CBFA2,EVI-1,PEBP2aB,PEBP2alpha)FOXA1(HNF3A,TCF3A) |
TF experiment: | Reverse transcription quantitative PCR,RNA-seq,ChIP-seq,ChIP-qPCR,???? |
TF experiment description: | The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. ;The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. |
Enhancer function : | The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
The AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
RUNX1 | AndrogenReceptor | netpath | 167 |
RUNX1 | Organic cation transport | reactome | 9 |
RUNX1 | RANKL | netpath | 84 |
RUNX1 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
RUNX1 | TGF_beta_Receptor | netpath | 220 |
RUNX1 | Validated transcriptional targets of deltaNp63 isoforms | pid | 47 |
RUNX1 | Pathways in cancer | kegg | 321 |
RUNX1 | Chronic myeloid leukemia | kegg | 69 |
RUNX1 | Acute myeloid leukemia | kegg | 53 |
FOXA1 | AndrogenReceptor | netpath | 167 |
FOXA1 | Direct p53 effectors | pid | 141 |
FOXA1 | FOXA1 transcription factor network | pid | 45 |
FOXA1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
FOXA1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |